Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genetic Disease Diagnostic Market Perspective (2017-2028)
2.2 Genetic Disease Diagnostic Growth Trends by Region
2.2.1 Genetic Disease Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genetic Disease Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Genetic Disease Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Genetic Disease Diagnostic Market Dynamics
2.3.1 Genetic Disease Diagnostic Industry Trends
2.3.2 Genetic Disease Diagnostic Market Drivers
2.3.3 Genetic Disease Diagnostic Market Challenges
2.3.4 Genetic Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Diagnostic Players by Revenue
3.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Disease Diagnostic Revenue
3.4 Global Genetic Disease Diagnostic Market Concentration Ratio
3.4.1 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnostic Revenue in 2021
3.5 Genetic Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Genetic Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Genetic Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Disease Diagnostic Breakdown Data by Type
4.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2023-2028)
5 Genetic Disease Diagnostic Breakdown Data by Application
5.1 Global Genetic Disease Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genetic Disease Diagnostic Market Size (2017-2028)
6.2 North America Genetic Disease Diagnostic Market Size by Type
6.2.1 North America Genetic Disease Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Genetic Disease Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Genetic Disease Diagnostic Market Share by Type (2017-2028)
6.3 North America Genetic Disease Diagnostic Market Size by Application
6.3.1 North America Genetic Disease Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Genetic Disease Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Genetic Disease Diagnostic Market Share by Application (2017-2028)
6.4 North America Genetic Disease Diagnostic Market Size by Country
6.4.1 North America Genetic Disease Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Genetic Disease Diagnostic Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Genetic Disease Diagnostic Market Size (2017-2028)
7.2 Europe Genetic Disease Diagnostic Market Size by Type
7.2.1 Europe Genetic Disease Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Genetic Disease Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Genetic Disease Diagnostic Market Share by Type (2017-2028)
7.3 Europe Genetic Disease Diagnostic Market Size by Application
7.3.1 Europe Genetic Disease Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Genetic Disease Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Genetic Disease Diagnostic Market Share by Application (2017-2028)
7.4 Europe Genetic Disease Diagnostic Market Size by Country
7.4.1 Europe Genetic Disease Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Genetic Disease Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Type
8.2.1 Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Genetic Disease Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Application
8.3.1 Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Genetic Disease Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Genetic Disease Diagnostic Market Size by Region
8.4.1 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genetic Disease Diagnostic Market Size (2017-2028)
9.2 Latin America Genetic Disease Diagnostic Market Size by Type
9.2.1 Latin America Genetic Disease Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Genetic Disease Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Genetic Disease Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Genetic Disease Diagnostic Market Size by Application
9.3.1 Latin America Genetic Disease Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Genetic Disease Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Genetic Disease Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Genetic Disease Diagnostic Market Size by Country
9.4.1 Latin America Genetic Disease Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Genetic Disease Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Type
10.2.1 Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Genetic Disease Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Application
10.3.1 Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Genetic Disease Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Country
10.4.1 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Genetic Disease Diagnostic Introduction
11.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Genetic Disease Diagnostic Introduction
11.2.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.2.5 PerkinElmer Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Genetic Disease Diagnostic Introduction
11.3.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.3.5 Roche Diagnostics Recent Developments
11.4 Bio Rad
11.4.1 Bio Rad Company Details
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Genetic Disease Diagnostic Introduction
11.4.4 Bio Rad Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.4.5 Bio Rad Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Genetic Disease Diagnostic Introduction
11.6.4 BGI Group Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.6.5 BGI Group Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Genetic Disease Diagnostic Introduction
11.7.4 Berry Genomics Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.7.5 Berry Genomics Recent Developments
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Details
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.8.5 Da An Gene Co., Ltd. Recent Developments
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Genetic Disease Diagnostic Introduction
11.9.4 Illumina Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.9.5 Illumina Recent Developments
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Genetic Disease Diagnostic Introduction
11.10.4 CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.10.5 CapitalBio Technology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer